StudyParticipation FHIR Resource Proposal
- 1 StudyParticipation
- 1.1 Owning committee name
- 1.2 Committee Approval Date:
- 1.3 Contributing or Reviewing Work Groups
- 1.4 FHIR Resource Development Project Insight ID
- 1.5 Scope of coverage
- 1.6 RIM scope
- 1.7 Resource appropriateness
- 1.8 Expected implementations
- 1.9 Content sources
- 1.10 Example Scenarios
- 1.11 Resource Relationships
- 1.12 Timelines
- 1.13 gForge Users
- 1.14 When Resource Proposal Is Complete
Owning committee name
Committee Approval Date:
Contributing or Reviewing Work Groups
FHIR Resource Development Project Insight ID
Scope of coverage
This resource manages the linkage between a study subject (Patient) and a particular study. It covers both human and animal subjects and captures information about their participation in the study - what arm they were assigned to, what arm they actually completed, when they started and stopped participation, etc.
Observation[classCode=CLNTRL, moodCode=EVN] (A StudyParticipation is essentially a mini clinical trial with a subject of 1 from a RIM perspective)
A key aspect of tracking research studies is tracking the involvement of the individual study subjects. This information is relevant to care delivery (is my patient a member of any clinical trials), trial management and trial result reporting. Each participation has its own status. Access permissions may vary for different sets of participants for different users. Each participation can have its own id, though these are typically captured on the study subject themselves (i.e. the patient). This resource is needed to support DAF research, for mapping BRIDG to FHIR and for mapping CDISC specifications to FHIR. The number of data elements should be closer to the 20 side than the 50 side.
DAF research, BRIDG and CDISC mappings, and potential future use in clinical research submission specificaitons.
BRIDG, SDTM/SEND, pCOREnet
Track study enrollment, current patient status, what arm the patient was assigned to, what stage of the trail the patient is in, when they left the trial, reason for leaving the trial, etc.
Will always be linked to a Study and a Patient. May be linked to other relevant data (though more likely to have data linked directly to study?
Intention is to have a draft included in the STU 3 publication (for DAF Research) as a placeholder. STU in release 4
Rik Smithies, Lloyd McKenzie (already have committer access)
When Resource Proposal Is Complete
When you have completed your proposal, please send an email to FMGcontact@HL7.org